CytoDyn, Inc. (CYDY)
0.20
0.00 (0.00%)
USD |
OTCM |
Oct 14, 16:00
CytoDyn Shareholders Equity (Quarterly) : -98.07M for Aug. 31, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2026 | -98.07M |
| May 31, 2026 | -109.72M |
| February 28, 2026 | -104.29M |
| November 30, 2025 | -119.75M |
| August 31, 2025 | -99.50M |
| May 31, 2025 | -96.04M |
| February 28, 2025 | -92.98M |
| November 30, 2024 | -89.39M |
| August 31, 2024 | -85.21M |
| May 31, 2024 | -116.76M |
| February 29, 2024 | -119.38M |
| November 30, 2023 | -114.38M |
| August 31, 2023 | -116.89M |
| May 31, 2023 | -109.50M |
| February 28, 2023 | -107.01M |
| November 30, 2022 | -115.97M |
| August 31, 2022 | -94.31M |
| May 31, 2022 | -94.40M |
| February 28, 2022 | -22.46M |
| November 30, 2021 | -12.70M |
| August 31, 2021 | -25.19M |
| May 31, 2021 | -21.02M |
| February 28, 2021 | -15.80M |
| November 30, 2020 | -6.534M |
| August 31, 2020 | 2.768M |
| Date | Value |
|---|---|
| May 31, 2020 | -2.480M |
| February 29, 2020 | -4.383M |
| November 30, 2019 | -13.63M |
| August 31, 2019 | -6.795M |
| May 31, 2019 | -8.914M |
| February 28, 2019 | -6.249M |
| November 30, 2018 | -8.064M |
| August 31, 2018 | -19.80M |
| May 31, 2018 | -13.16M |
| February 28, 2018 | -7.593M |
| November 30, 2017 | -12.79M |
| August 31, 2017 | -8.358M |
| May 31, 2017 | -1.103M |
| February 28, 2017 | 5.417M |
| November 30, 2016 | 5.377M |
| August 31, 2016 | 6.253M |
| May 31, 2016 | 10.21M |
| February 29, 2016 | 11.21M |
| November 30, 2015 | -2.709M |
| August 31, 2015 | -6.714M |
| May 31, 2015 | -10.69M |
| February 28, 2015 | -3.699M |
| November 30, 2014 | -1.689M |
| August 31, 2014 | 0.6802M |
| May 31, 2014 | 3.922M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 19.05M |
| Total Liabilities (Quarterly) | 117.13M |
| Debt to Equity Ratio | -0.2781 |
| Current Ratio | 0.382 |
| Net Debt Paydown Yield | 0.00% |